Using HAd5 vectors to express a combination of TAAs, such as CEA + brachyury + MUC1 and CEA + brachyury + mucin 1 (MUC1) + Her2 are also used to promote cancer vaccination.82 The gene discussed is CEACAM5; the disease is cancer.